6,603 Shares in USANA Health Sciences, Inc. (NYSE:USNA) Acquired by Quest Partners LLC

Quest Partners LLC bought a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 6,603 shares of the company’s stock, valued at approximately $250,000.

Other hedge funds have also recently modified their holdings of the company. State Board of Administration of Florida Retirement System increased its holdings in shares of USANA Health Sciences by 22.7% in the first quarter. State Board of Administration of Florida Retirement System now owns 8,430 shares of the company’s stock valued at $409,000 after purchasing an additional 1,560 shares during the period. BOKF NA lifted its stake in USANA Health Sciences by 274.5% during the 1st quarter. BOKF NA now owns 2,771 shares of the company’s stock valued at $133,000 after acquiring an additional 2,031 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of USANA Health Sciences by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after acquiring an additional 494 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its stake in shares of USANA Health Sciences by 2.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 111,492 shares of the company’s stock worth $5,407,000 after acquiring an additional 2,820 shares during the period. Finally, First Hawaiian Bank raised its holdings in shares of USANA Health Sciences by 36.9% during the second quarter. First Hawaiian Bank now owns 12,439 shares of the company’s stock worth $563,000 after purchasing an additional 3,350 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

Insiders Place Their Bets

In other news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Separately, DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a report on Wednesday, October 23rd.

USANA Health Sciences Price Performance

Shares of NYSE USNA opened at $38.01 on Wednesday. The firm’s 50 day simple moving average is $37.86 and its 200-day simple moving average is $41.64. USANA Health Sciences, Inc. has a 12 month low of $34.15 and a 12 month high of $54.81. The stock has a market capitalization of $724.38 million, a price-to-earnings ratio of 13.74, a PEG ratio of 1.36 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million for the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same quarter in the prior year, the business posted $0.59 earnings per share. Analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.